Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Fennec Pharmaceuticals is a US-based pharmaceutical company dedicated to developing innovative medicines and therapies. The company's focus lies in research, development, and commercialization, aiming to enhance patient health globally through scientific advancements in the pharmaceutical industry.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Fennec Pharmaceuticals is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Fennec Pharmaceuticals last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at 0.07 CAD.
Across its last 3 earnings reports, Fennec Pharmaceuticals stock moved by ±19.6% on average the following day. The largest reaction was +36.5% on 05/14/2026; 1 of 3 reactions were positive.
Fennec Pharmaceuticals has beaten analyst EPS estimates in 3 of its last 6 evaluated quarters (beat rate: 50%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.